Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
To help consumers receive discounts promised by the pharmaceutical industry, Amazon.com said on Tuesday that its online pharmacy will automatically apply manufacturer-sponsored coupons to more than 15 insulin and diabetic medications.
According to the firm, patients using Amazon Pharmacy will no longer need to manually look for and submit discounts from the three biggest insulin manufacturers, Novo Nordisk, Eli Lilly, and Sanofi, in order to reduce the price of their insulin to as little as $35 for a month’s supply.
Despite pledges from Novo, Lilly, and Sanofi to reduce insulin costs by at least 70% by or before 2024, a report from Senator Elizabeth Warren published last month claimed that some patients were having trouble obtaining generic insulin from pharmacies at the promised lower price.
Read Next: Amazon Empowers Accessibility: Alexa Receives New Updates to Enhance Features
Automatic Insulin Discounts Aim to Aid Patients
Despite promises from Novo, Lilly, and Sanofi to cut insulin prices by at least 70% by or before 2024, a study from Senator Elizabeth Warren released this month stated that some patients were having difficulty acquiring generic insulin from pharmacies at the promised lower price.
The findings, according to Vin Gupta, Chief Medical Officer of Amazon Pharmacy, underscored the necessity of making it simpler for people to obtain their insulin at the most affordable pricing.
Together with other cardiometabolic medications like Novo’s potent weight-loss treatment Wegovy, Amazon Pharmacy will automatically apply any applicable discounts to diabetes-related medical devices from makers Dexcom and Insulet, such as continuous glucose monitors and pumps.
According to Charles Henderson, chief executive officer of the American Diabetes Association, Amazon’s automatic discounting will make it easier for the 37 million People who have diabetes to get the necessary treatments.
Since beginning its healthcare business in late 2020, Amazon has attempted to entice customers away from more reputable pharmacies like CVS and Walgreens. This month, the company said that the number of active pharmacy users had doubled over the previous year.
Read Next: Amazon’s Q2 Stock Price Surge Reignites Interest Among Prominent Investors
Source: Reuters
